Qi Tan

Title: Innovations in Tumor Treatment: The Contributions of Qi Tan

Introduction

Qi Tan is a notable inventor based in Wuhan, China. He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. His work focuses on utilizing metabolic inhibitors to enhance tumor treatment efficacy.

Latest Patents

Qi Tan holds a patent for the "Preparation method and application of tumor microparticles encapsulating metabolic inhibitors." This preparation method involves cultivating tumor cells and adding a statin drug to the culture medium. After the tumor cells grow stably, they are irradiated with ultraviolet light and incubated for 22 to 26 hours. The resulting cell supernatant is then collected, and tumor microparticles encapsulating the metabolic inhibitor are obtained through gradient centrifugation. This method utilizes tumor cell-derived microparticles as drug delivery platforms, ensuring biosafety, biocompatibility, targeting, and intercellular communication. The discovery of new uses for statin drugs can inhibit tumor growth, regulate tumor metabolism, and improve the tumor microenvironment, potentially enhancing chemotherapy efficacy and delaying chemotherapy resistance.

Career Highlights

Qi Tan is affiliated with Huazhong University of Science and Technology, where he conducts his research. His innovative approach to cancer treatment has garnered attention in the scientific community. His work exemplifies the intersection of research and practical application in the medical field.

Collaborations

Qi Tan collaborates with esteemed colleagues such as Yang Jin and WenJuan Chen. Their combined expertise contributes to the advancement of cancer treatment methodologies.

Conclusion

Qi Tan's innovative work in developing tumor microparticles encapsulating metabolic inhibitors represents a significant advancement in cancer treatment. His contributions have the potential to improve patient outcomes and enhance the efficacy of chemotherapy.